Medicine utilisation and pricing in Malaysia: The findings of a household survey

Zaheer Ud din Babar, Izham Mohamed Ibrahim Mohamed, Nadeem Irfan Bukhari

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The objectives of this study were to identify the most commonly used medicines for mainly prevalent ailments and to compare retail sector prices (RSPs), public sector prices (PSPs) and international reference prices (IRPs). A convenient sampling method was employed to survey 33 households in a metropolitan city. Each family was followed once a week for eight weeks to observe their diseases and medication usage. The RSPs and PSPs for per unit doses and defined daily doses (DDDs) were compared with the IRPs. The most common ailments identified were cardiovascular and endocrine disorders followed by central nervous system and musculoskeletal disorders. Accordingly, the most common drugs used were for the treatment of the above ailments. Among 81 commonly used medicines, 63 were branded and 18 were generic. Of the 81 drugs, 26 were essential drugs. Angiotensin-converting enzyme (ACE) inhibitors, beta-blockers and calcium channel blockers were among the most commonly used medicines. The differential between the prices of branded medicines and IRPs were found to be remarkable. This study further revealed that the majority of patients also used traditional medicines and nutritional supplements alongside their modern medicines. Wide variations were observed in RSPs and IRPs, warranting critical evaluation, regulation and emphasis on the economic aspects of drug policy. Widespread use of branded medicines in the absence of a national health insurance programme can lead to high out-of-pocket expenditures. Concomitant use of traditional medicines and nutritional supplements may have drug interaction potential, invoking detailed investigation for relevance.

LanguageEnglish
Pages47-61
Number of pages15
JournalJournal of Generic Medicines
Volume3
Issue number1
Publication statusPublished - 1 Oct 2005
Externally publishedYes

Fingerprint

Malaysia
Medicine
Costs and Cost Analysis
Public Sector
National Health Programs
Traditional Medicine
Surveys and Questionnaires
Pharmaceutical Preparations
Essential Drugs
Modern 1601-history
Central Nervous System Diseases
Calcium Channel Blockers
Health Expenditures
Drug Interactions
Angiotensin-Converting Enzyme Inhibitors
Economics

Cite this

din Babar, Zaheer Ud ; Ibrahim Mohamed, Izham Mohamed ; Bukhari, Nadeem Irfan. / Medicine utilisation and pricing in Malaysia : The findings of a household survey. In: Journal of Generic Medicines. 2005 ; Vol. 3, No. 1. pp. 47-61.
@article{8a6e007092ff4d9f8655021de1cdbdbe,
title = "Medicine utilisation and pricing in Malaysia: The findings of a household survey",
abstract = "The objectives of this study were to identify the most commonly used medicines for mainly prevalent ailments and to compare retail sector prices (RSPs), public sector prices (PSPs) and international reference prices (IRPs). A convenient sampling method was employed to survey 33 households in a metropolitan city. Each family was followed once a week for eight weeks to observe their diseases and medication usage. The RSPs and PSPs for per unit doses and defined daily doses (DDDs) were compared with the IRPs. The most common ailments identified were cardiovascular and endocrine disorders followed by central nervous system and musculoskeletal disorders. Accordingly, the most common drugs used were for the treatment of the above ailments. Among 81 commonly used medicines, 63 were branded and 18 were generic. Of the 81 drugs, 26 were essential drugs. Angiotensin-converting enzyme (ACE) inhibitors, beta-blockers and calcium channel blockers were among the most commonly used medicines. The differential between the prices of branded medicines and IRPs were found to be remarkable. This study further revealed that the majority of patients also used traditional medicines and nutritional supplements alongside their modern medicines. Wide variations were observed in RSPs and IRPs, warranting critical evaluation, regulation and emphasis on the economic aspects of drug policy. Widespread use of branded medicines in the absence of a national health insurance programme can lead to high out-of-pocket expenditures. Concomitant use of traditional medicines and nutritional supplements may have drug interaction potential, invoking detailed investigation for relevance.",
keywords = "Defined daily doses, Drug policy, Drug prices, Drug utilisation, International reference prices, Medicine price index",
author = "{din Babar}, {Zaheer Ud} and {Ibrahim Mohamed}, {Izham Mohamed} and Bukhari, {Nadeem Irfan}",
year = "2005",
month = "10",
day = "1",
language = "English",
volume = "3",
pages = "47--61",
journal = "Journal of Generic Medicines",
issn = "1741-1343",
publisher = "Palgrave Macmillan Ltd.",
number = "1",

}

Medicine utilisation and pricing in Malaysia : The findings of a household survey. / din Babar, Zaheer Ud; Ibrahim Mohamed, Izham Mohamed; Bukhari, Nadeem Irfan.

In: Journal of Generic Medicines, Vol. 3, No. 1, 01.10.2005, p. 47-61.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Medicine utilisation and pricing in Malaysia

T2 - Journal of Generic Medicines

AU - din Babar, Zaheer Ud

AU - Ibrahim Mohamed, Izham Mohamed

AU - Bukhari, Nadeem Irfan

PY - 2005/10/1

Y1 - 2005/10/1

N2 - The objectives of this study were to identify the most commonly used medicines for mainly prevalent ailments and to compare retail sector prices (RSPs), public sector prices (PSPs) and international reference prices (IRPs). A convenient sampling method was employed to survey 33 households in a metropolitan city. Each family was followed once a week for eight weeks to observe their diseases and medication usage. The RSPs and PSPs for per unit doses and defined daily doses (DDDs) were compared with the IRPs. The most common ailments identified were cardiovascular and endocrine disorders followed by central nervous system and musculoskeletal disorders. Accordingly, the most common drugs used were for the treatment of the above ailments. Among 81 commonly used medicines, 63 were branded and 18 were generic. Of the 81 drugs, 26 were essential drugs. Angiotensin-converting enzyme (ACE) inhibitors, beta-blockers and calcium channel blockers were among the most commonly used medicines. The differential between the prices of branded medicines and IRPs were found to be remarkable. This study further revealed that the majority of patients also used traditional medicines and nutritional supplements alongside their modern medicines. Wide variations were observed in RSPs and IRPs, warranting critical evaluation, regulation and emphasis on the economic aspects of drug policy. Widespread use of branded medicines in the absence of a national health insurance programme can lead to high out-of-pocket expenditures. Concomitant use of traditional medicines and nutritional supplements may have drug interaction potential, invoking detailed investigation for relevance.

AB - The objectives of this study were to identify the most commonly used medicines for mainly prevalent ailments and to compare retail sector prices (RSPs), public sector prices (PSPs) and international reference prices (IRPs). A convenient sampling method was employed to survey 33 households in a metropolitan city. Each family was followed once a week for eight weeks to observe their diseases and medication usage. The RSPs and PSPs for per unit doses and defined daily doses (DDDs) were compared with the IRPs. The most common ailments identified were cardiovascular and endocrine disorders followed by central nervous system and musculoskeletal disorders. Accordingly, the most common drugs used were for the treatment of the above ailments. Among 81 commonly used medicines, 63 were branded and 18 were generic. Of the 81 drugs, 26 were essential drugs. Angiotensin-converting enzyme (ACE) inhibitors, beta-blockers and calcium channel blockers were among the most commonly used medicines. The differential between the prices of branded medicines and IRPs were found to be remarkable. This study further revealed that the majority of patients also used traditional medicines and nutritional supplements alongside their modern medicines. Wide variations were observed in RSPs and IRPs, warranting critical evaluation, regulation and emphasis on the economic aspects of drug policy. Widespread use of branded medicines in the absence of a national health insurance programme can lead to high out-of-pocket expenditures. Concomitant use of traditional medicines and nutritional supplements may have drug interaction potential, invoking detailed investigation for relevance.

KW - Defined daily doses

KW - Drug policy

KW - Drug prices

KW - Drug utilisation

KW - International reference prices

KW - Medicine price index

UR - http://www.scopus.com/inward/record.url?scp=28444495892&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 47

EP - 61

JO - Journal of Generic Medicines

JF - Journal of Generic Medicines

SN - 1741-1343

IS - 1

ER -